Floatz logo

FILGRASTIM

Granulocyte Colony-Stimulating Factor

Nanfang Hospital, Southern Medical Universityprotein_peptidePhase 2/3Dormant
B
63/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
48/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Granulocyte Colony-Stimulating Factor cohort.

Asset / SponsorPhaseRating
Peg-Rhg-Csf
Ruijin Hospital
Phase 4BB
Rhgm-Csf
Ruijin Hospital
Phase 4BB
DEXAMETHASONE
Second Affiliated Hospital of Soochow University
Phase 2CCC
Bortezomib
Second Affiliated Hospital of Soochow University
Phase 2CCC
Inno-206
Second Affiliated Hospital of Soochow University
Phase 2CCC
PREDNISONE TABLETS
Second Affiliated Hospital of Soochow University
Phase 2CCC
Cyclophosphamide
Second Affiliated Hospital of Soochow University
Phase 2CCC

Same molecule, other indications

FILGRASTIM is also rated in:

plasma cell myelomaDormant
BBB
Indicative ·
79 / 100
View asset →
Burkitt lymphomaDormant
BBB
Indicative ·
78 / 100
View asset →
Hodgkins lymphomaDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →